Geneos Wealth Management’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.87M Buy
23,958
+1,626
+7% +$584K 0.18% 129
2025
Q4
$7.85M Sell
22,332
-367
-2% -$134K 0.19% 136
2025
Q3
$8.39M Sell
22,699
-433
-2% -$167K 0.21% 124
2025
Q2
$9.15M Sell
23,132
-16,696
-42% -$6.25M 0.22% 111
2025
Q1
$14.8M Buy
39,828
+25,810
+184% +$9.82M 0.21% 117
2024
Q4
$5.05M Buy
14,018
+92
+0.7% +$34.1K 0.18% 133
2024
Q3
$5.03M Buy
13,926
+262
+2% +$90.4K 0.19% 130
2024
Q2
$4.65M Buy
13,664
+216
+2% +$73.2K 0.21% 116
2024
Q1
$4.81M Sell
13,448
-796
-6% -$268K 0.22% 117
2023
Q4
$4.27M Sell
14,244
-266
-2% -$74.7K 0.21% 120
2023
Q3
$3.97M Buy
14,510
+170
+1% +$48.7K 0.2% 128
2023
Q2
$4.38M Buy
14,340
+575
+4% +$166K 0.23% 120
2023
Q1
$3.93M Sell
13,765
-2,043
-13% -$542K 0.24% 105
2022
Q4
$3.86M Buy
15,808
+595
+4% +$135K 0.23% 115
2022
Q3
$3.08M Sell
15,213
-671
-4% -$141K 0.21% 118
2022
Q2
$3.24M Buy
15,884
+654
+4% +$154K 0.16% 147
2022
Q1
$4.07M Buy
15,230
+1,662
+12% +$430K 0.17% 139
2021
Q4
$3.63M Buy
13,568
+759
+6% +$199K 0.14% 163
2021
Q3
$3.44M Buy
12,809
+647
+5% +$173K 0.13% 175
2021
Q2
$3.23M Sell
12,162
-2,155
-15% -$551K 0.13% 181
2021
Q1
$3.76M Buy
14,317
+1,549
+12% +$371K 0.1% 203
2020
Q4
$2.82M Buy
12,768
+1,859
+17% +$421K 0.11% 193
2020
Q3
$2.24M Buy
10,909
+290
+3% +$56.4K 0.12% 185
2020
Q2
$1.84M Buy
10,619
+1,764
+20% +$325K 0.1% 197
2020
Q1
$1.41M Buy
8,855
+6,950
+365% +$1.36M 0.09% 215
2019
Q4
$401K Buy
1,905
+30
+2% +$6.23K 0.02% 489
2019
Q3
$400K Hold
1,875
0.02% 461
2019
Q2
$385K Sell
1,875
-70
-4% -$13.4K 0.02% 486
2019
Q1
$384K Sell
1,945
-149
-7% -$26.8K 0.03% 470
2018
Q4
$324K Sell
2,094
-16
-0.8% -$2.68K 0.02% 468
2018
Q3
$374K Sell
2,110
-172
-8% -$29.4K 0.02% 452
2018
Q2
$385K Hold
2,282
0.03% 377
2018
Q1
$367K Buy
2,282
+288
+14% +$46.4K 0.03% 374
2017
Q4
$308K Buy
1,994
+119
+6% +$18.2K 0.03% 418
2017
Q3
$266K Buy
1,875
+350
+23% +$50.2K 0.03% 432
2017
Q2
$211K Hold
1,525
0.02% 486
2017
Q1
$200K Sell
1,525
-4
-0.3% -$505 0.02% 481
2016
Q4
$183K Hold
1,529
0.02% 474
2016
Q3
$177K Buy
1,529
+4
+0.3% +$466 0.02% 471
2016
Q2
$183K Hold
1,525
0.03% 461
2016
Q1
$165K Buy
+1,525
New +$150K 0.03% 472

Other funds holding SYK

Geneos Wealth Management's SYK Position: Q1 2026 in Review

Geneos Wealth Management increased its Stryker (SYK) stake by 7.3% in Q1 2026, buying an estimated $584K and bringing the position to 23,958 shares worth $7.87M. The position accounts for 0.18% of the portfolio, ranked #129.

Geneos Wealth Management first reported a position in SYK in Q1 2016 and has held it in 41 quarters since. The position peaked at $14.8M in Q1 2025. 2,293 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Geneos Wealth Management held 23,958 shares of Stryker worth $7.87M as of Q1 2026.
  • Geneos Wealth Management bought 1,626 Stryker shares in Q1 2026, an estimated $584K.
  • Stryker made up 0.18% of Geneos Wealth Management's portfolio in Q1 2026, its #129 holding.
  • Geneos Wealth Management first reported a position in Stryker in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Stryker position peaked at $14.8M in Q1 2025.
  • 2,293 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.